repu market expected to dive up 300+ points...... Blood Mode

[LadiesTailor]

Time to close trading for few weeks.... 

[Hydrockers]

Just now, LadiesTailor said:

Time to close trading for few weeks.... 

Jnug tisukoni unte manchi +ve lo unde vadivi ga

Gattiga shopping chese vadivi ga

[Vaampire]

All in JDST @4.4 pre market

stop loss placed at 3.5, sell order placed at 7. Will change the sell order based on how it goes.

[nag_mama]

1 hour ago, LadiesTailor said:

Time to close trading for few weeks.... 

[karna11]

ee roju enni points padochuu  dow mee number seppandi vayya

mine 2100

 

[Hydrockers]

Just now, karna11 said:

ee roju enni points padochuu  dow mee number seppandi vayya

mine 2100

 

Above 8 %

[nag_mama]

11 minutes ago, karna11 said:

ee roju enni points padochuu  dow mee number seppandi vayya

mine 2100

 

1000

[Sucker]

1 hour ago, Hydrockers said:

Jnug tisukoni unte manchi +ve lo unde vadivi ga

Gattiga shopping chese vadivi ga

Baa shopping list veyyu with rates 

[nag_mama]

Japanese flu drug could be effective in treating coronavirus, report says

PUBLISHED WED, MAR 18 20208:43 AM EDT

 

Sam Meredith@SMEREDITH19

 

 

 

 

KEY POINTS

• Patients treated with the drug, which was developed by a subsidiary of Fujifilm, in Shenzen were found to turn negative for COVID-19 after a median of four days, rather than 11 days for those who were not treated with favipiravir, NHK reported.
• The WHO has recognized the coronavirus outbreak as a pandemic.

 

A worker wearing protective suit checks the body temperature of an employee at the entrance of OrbusNeich Medical (Shenzhen) Co. Ltd amid the coronavirus outbreak on March 6, 2020 in Shenzhen, Guangdong Province of China.

Chen Wen | China News Service via Getty Images

Chinese medical authorities have claimed a drug used in Japan to treat new strains of influenza appears to be effective for those infected with the coronavirus, Japan’s state broadcaster NHK reported.

Zhang Xinmin, director of China’s National Center for Biotechnology Development, said the favipiravir drug had produced positive outcomes during clinical trials in Wuhan and Shenzen. The report on Tuesday said 340 patients had taken part in the clinical trials.

 

“It has a high degree of safety and is clearly effective in treatment,” Zhang told reporters.

Patients treated with the drug, which was developed by a subsidiary of Fujifilm, in Shenzen were found to turn negative for COVID-19 after a median of four days, rather than 11 days for those who were not treated with favipiravir, NHK reported.

As of Wednesday, more than 200,000 people worldwide were reported to have contracted the coronavirus, according to data compiled by Johns Hopkins University, with over 8,000 deaths.

The WHO has recognized the coronavirus outbreak as a pandemic.

[Simple123]

BOUGHT MDLA , PSEC , STM, WORK, JD, NXPI  this morning

[Hydrockers]

3 minutes ago, Sucker said:

Baa shopping list veyyu with rates 

Contact chill thata @rajaa

[Sucker]

1 minute ago, Hydrockers said:

Contact chill thata @rajaa

Thank you sheeyam sir dad 

[karna11]

@k2s @Spartan  entii ee roju paristhi, sa,e as it is aa?

 

[VictoryTDP]

TSLA $388 Inka paduthunda?

[Sucker]

Dailybpadatam thatha press meet lu tweet lantho lepaniki try cheyyatam.